Carolinas Wealth Consulting’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $26.6K | Buy |
|
|||||
|
2024
Q4 | $29.2K | Sell |
|
|||||
|
2024
Q3 | $51.5K | Buy |
|
|||||
|
2024
Q2 | $49.4K | Sell |
|
|||||
|
2024
Q1 | $47.2K | Buy |
|
|||||
|
2023
Q4 | $42.2K | Hold |
|
|||||
|
2023
Q3 | $37.4K | Sell |
|
|||||
|
2023
Q2 | $37.4K | Sell |
|
|||||
|
2023
Q1 | $55.9K | Sell |
|
|||||
|
2022
Q4 | $56.3K | Hold |
|
|||||
|
2022
Q3 | $54K | Buy |
|
|||||
|
2022
Q2 | $33K | Hold |
|
|||||
|
2022
Q1 | $39K | Sell |
|
|||||
|
2021
Q4 | $36K | Hold |
|
|||||
|
2021
Q3 | $34K | Buy |
|
|||||
|
2021
Q2 | $31K | Sell |
|
|||||
|
2021
Q1 | $27K | Hold |
|
|||||
|
2020
Q4 | $28K | Hold |
|
|||||
|
2020
Q3 | $32K | Buy |
|
|||||
|
2020
Q2 | $22K | Buy |
|